Stephen Helmke

1.8k total citations
57 papers, 1.0k citations indexed

About

Stephen Helmke is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Stephen Helmke has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 28 papers in Nephrology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Stephen Helmke's work include Amyloidosis: Diagnosis, Treatment, Outcomes (40 papers), Parathyroid Disorders and Treatments (25 papers) and Heart Failure Treatment and Management (8 papers). Stephen Helmke is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (40 papers), Parathyroid Disorders and Treatments (25 papers) and Heart Failure Treatment and Management (8 papers). Stephen Helmke collaborates with scholars based in United States, Portugal and Australia. Stephen Helmke's co-authors include Mathew S. Maurer, Sergio Teruya, Julissa Alvarez, Adam Castaño, Susan Delisle, Jeff Goldsmith, Hannah Rosenblum, Jeffery W. Kelly, Jeffeny De Los Santos and Matthew J. Maurer and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Stephen Helmke

51 papers receiving 1000 citations

Peers

Stephen Helmke
Sergio Teruya United States
Stephen Helmke
Citations per year, relative to Stephen Helmke Stephen Helmke (= 1×) peers Sergio Teruya

Countries citing papers authored by Stephen Helmke

Since Specialization
Citations

This map shows the geographic impact of Stephen Helmke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Helmke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Helmke more than expected).

Fields of papers citing papers by Stephen Helmke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Helmke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Helmke. The network helps show where Stephen Helmke may publish in the future.

Co-authorship network of co-authors of Stephen Helmke

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Helmke. A scholar is included among the top collaborators of Stephen Helmke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Helmke. Stephen Helmke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Teruya, Sergio, et al.. (2024). Outpatient Worsening of Heart Failure and Mortality in Transthyretin Amyloid Cardiomyopathy. European Journal of Heart Failure. 27(12). 2961–2970. 5 indexed citations
3.
Fine, Denise, Stephen Helmke, Farbod Raiszadeh, et al.. (2023). Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Journal of the American Heart Association. 12(15). e028973–e028973. 17 indexed citations
4.
Chan, Nicholas, Sergio Teruya, Jeffeny De Los Santos, et al.. (2023). Abstract 14362: The Columbia Score Predicts Incident Atrial Fibrillation and Flutter in Patients With Transthyretin Cardiac Amyloidosis. Circulation. 148(Suppl_1). 1 indexed citations
5.
Einstein, Andrew J., Nicholas Chan, Akiva Mintz, et al.. (2023). In the thick of it: hereditary cardiac amyloidosis identified by 124I-AT-01 PET imaging but not cardiac MRI or SPECT 99mTc pyrophosphate scintigraphy. Journal of Nuclear Cardiology. 30(3). 1258–1262. 4 indexed citations
6.
Cohn, Ellen G., Sergio Teruya, Varsha Muralidhar, et al.. (2023). Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study. PLoS ONE. 18(3). e0283730–e0283730. 1 indexed citations
7.
Batra, Jaya, Hannah Rosenblum, Ersilia M. DeFilippis, et al.. (2020). Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure–Volume Analysis. Journal of Cardiac Failure. 27(1). 67–74. 20 indexed citations
8.
Batra, Jaya, et al.. (2020). SEX DIFFERENCES IN THE PHENOTYPE OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS DUE TO VAL122ILE MUTATIONS: INSIGHTS FROM NON-INVASIVE PRESSURE-VOLUME ANALYSIS. Journal of the American College of Cardiology. 75(11). 876–876. 1 indexed citations
9.
Chen, Peiyu, Stephen Helmke, Sergio Teruya, et al.. (2020). Insufficient Calorie Intake Worsens Post-Discharge Quality of Life and Increases Readmission Burden in Heart Failure. JACC Heart Failure. 8(9). 756–764. 26 indexed citations
10.
Brannagan, Thomas H., et al.. (2020). Early-Onset of Transthyretin Amyloidosis in a Young Afro-Caribbean Woman With Thr60Ala Mutation. SHILAP Revista de lepidopterología. 2(13). 2063–2067. 3 indexed citations
11.
Mitrani, Lindsey, Elissa Driggin, Jeffeny De Los Santos, Stephen Helmke, & Mathew S. Maurer. (2019). Abstract 14004: Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy May Present With Controlled Ventricular Response: A Retrospective Study. Circulation. 1 indexed citations
12.
Driggin, Elissa, et al.. (2019). MODIFIED BODY MASS INDEX IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS: ASSOCIATION WITH OUTCOMES AND THE CLINICAL PHENOTYPE. Journal of the American College of Cardiology. 73(9). 743–743.
14.
Monteiro, Cecília, Marta Novais, Aleksandra Baranczak, et al.. (2014). Quantification of Transthyretin Kinetic Stability in Human Plasma Using Subunit Exchange. Biochemistry. 53(12). 1993–2006. 71 indexed citations
16.
Castaño, Adam, Stephen Helmke, Julissa Alvarez, Susan Delisle, & Mathew S. Maurer. (2012). Diflunisal for ATTR Cardiac Amyloidosis. Congestive Heart Failure. 18(6). 315–319. 135 indexed citations
17.
Maurer, Matthew J., et al.. (2011). CHANGES IN THE TYPE OF CARDIAC AMYLOIDOSIS DIAGNOSED AT A TERTIARY REFERRAL CENTER: ONE IMPACT OF AN AGING POPULATION. Journal of the American College of Cardiology. 57(14). E247–E247. 1 indexed citations
18.
Altincatal, Arman, Robert B. MacArthur, Sergio Teruya, Stephen Helmke, & Matthew J. Maurer. (2011). A Dosing Algorithm for Erythropoietin Alpha in Older Adults with Heart Failure and a Preserved Ejection Fraction. Cardiovascular Therapeutics. 31(2). 92–99. 2 indexed citations
19.
Teruya, Sergio, et al.. (2011). Blood Volume Measurements in Patients With Heart Failure and a Preserved Ejection Fraction: Implications for Diagnosing Anemia. Congestive Heart Failure. 17(1). 14–18. 18 indexed citations
20.
Rosenblum, Hannah, Stephen Helmke, Paula Williams, et al.. (2010). Peak Cardiac Power Measured Noninvasively With a Bioreactance Technique Is a Predictor of Adverse Outcomes in Patients With Advanced Heart Failure. Congestive Heart Failure. 16(6). 254–258. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026